Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of Marketing"
DOI: 10.1177/00222429231177627
Abstract: Specialty drugs treat complex, severe diseases and offer significant therapeutic advances. Despite their potential to transform patient care, little is known about the drivers of their diffusion. In this study the authors develop a framework…
read more here.
Keywords:
diffusion;
scientific evidence;
evidence production;
specialty ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Health affairs"
DOI: 10.1377/hlthaff.2019.00201
Abstract: We found wide variation in the evidence that US commercial health plans reported reviewing in their specialty drug coverage policies. There was little consistency in the numbers or types of studies cited by health plans.…
read more here.
Keywords:
little consistency;
evidence;
drug;
coverage ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2019.25.2.178
Abstract: BACKGROUND The federal 340B Drug Discount Program provides access to significant drug price discounts for health care organizations in the United States that serve a disproportional share of disadvantaged patients. OBJECTIVE To analyze trends over…
read more here.
Keywords:
drug price;
year;
drug;
price ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2023.29.3.257
Abstract: BACKGROUND: The Institute for Clinical and Economic Review (ICER) has emerged in a visible role in US health care. However, it is unclear to what extent US commercial health plans use ICER value assessments in…
read more here.
Keywords:
health;
health plans;
coverage;
drug coverage ... See more keywords